Well done! [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2012-10-09 21:43 (4996 d 22:55 ago) – Posting: # 9362
Views: 17,295

Dear Detlew,

good anwer!

❝ On the other hand the reliable estimation of the terminal rate constant which is needed for a reliable estimate of AUC(0-inf) has the one and only purpose to assure that the observation time is long enough for ensuring that AUC(0-tlast) covers at least 80% of the AUC(0-inf) (or the other way round that the residual area AUC(tlast-inf) is <=20% of AUC(0-inf)).


❝ AUC(0-inf) in itself is not a primary endpoint on which the bioequivalence decision will be based (not according to the EMA guidance and also not according to the Study protocol). The bioequivalence decision taken in the Study Report is thus in no way affected by the way of calculation of the terminal rate constant.


Agree, but some hard-core assessor might tell you that if you cannot reliably estimate AUC you have not demonstrated that AUCt is an acceptable metric for the BE assessment. That’s a vicious circle.

BTW, I didn’t want to go to much off-topic (as I did above) and started another thread about analytical variability.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
104 visitors (0 registered, 104 guests [including 12 identified bots]).
Forum time: 20:39 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5